NPS Preos Fracture Reduction, Bone Density Data To TOP Off Late-2004 NDA
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
NPS’ recombinant human parathyroid hormone Preos has shown a statistically significant 59% relative reduction in vertebral fracture risk in women with mild to moderate osteoporosis in the pivotal TOP study.